Total raised
$9K
Stage
Pre-Funding
Founded
2025
Headcount
2
HQ
Haifa
Sector
Health Tech & Life Sciences
About
FiBreath was created to address the global burden of respiratory disease. The company’s vision is to empower over 100 million asthma and COPD patients to breathe more easily and reclaim active lives. Operating in stealth mode, FiBreath is developing a novel inhaled‑therapy platform designed for deep‑lung delivery and enhanced patient outcomes. The business model focuses on licensing its platform to leading pharmaceutical and inhaler manufacturers in exchange for royalties.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesHealthcareProvidersInsurance CompaniesLife SciencesPharmaceuticalsBiotechnologyMedical Devices IndustryMedical Products
Business model
B2B
Highlights
Verified
Tags
inhalationasthmarespiratorystealthmodedrug-delivery